Platelet Indices and CXCL12 Levels in Patients with Intrauterine Growth Restriction

References

• Walker D, Marlow N. Neurocognitive outcome following fetal growth restriction. Arch Dis Childhood Fetal Neonatal Ed. 2008;93(4):F322–F325. doi:10.1136/adc.2007.120485
   Web of Science ®Google Scholar
• Murray E, Fernandes M, Fazel M, Kennedy S, Villar J, Stein A. Differential effect of intrauterine growth restriction on childhood neurodevelopment: a systematic review. BJOG. 2015;122(8):1062–1072. doi:10.1111/1471-0528.13435
   PubMed Web of Science ®Google Scholar
• Romo A, Carceller R, Tobajas J. Intrauterine growth retardation (IUGR): epidemiology and etiology. Pediatr Endocrinol Rev. 2009;6(Suppl 3):332–336.
   PubMedGoogle Scholar
• Sharma D, Shastri S, Farahbakhsh N, Sharma P. Intrauterine growth restriction - part 1. J Mater Fetal Neonatal Med. 2016;29(24):3977–3987. doi:10.3109/14767058.2016.1152249
   PubMed Web of Science ®Google Scholar
• Blössner M, Villar J. Levels and patterns of intrauterine growth retardation in developing countries. Eur J Clin Nutr. 1998;52:S5–15.
   Web of Science ®Google Scholar
• Sharma D, Sharma P, Shastri S. Genetic, metabolic and endocrine aspect of intrauterine growth restriction: an update. J Mater Fetal Neonatal Med. 2017;30(19):2263–2275. doi:10.1080/14767058.2016.1245285
   PubMed Web of Science ®Google Scholar
• Wen SW, Goldenberg RL, Cutter GR, Hoffman HJ, Cliver SP. Intrauterine growth retardation and preterm delivery: prenatal risk factors in an indigent population. Am J Obstet Gynecol. 1990;162(1):213–218. doi:10.1016/0002-9378(90)90853-Y
   Web of Science ®Google Scholar
• Kleijer ME, Dekker GA, Heard AR. Risk factors for intrauterine growth restriction in a socio-economically disadvantaged region. J Mater Fetal Neonatal Med. 2005;18(1):23–30. doi:10.1080/14767050500127674
   PubMed Web of Science ®Google Scholar
• Kanat‐Pektas M, Yesildager U, Tuncer N, Arioz DT, Nadirgil‐Koken G, Yilmazer M. Could mean platelet volume in late first trimester of pregnancy predict intrauterine growth restriction and pre‐eclampsia? J Obstetrics Gynaecol Res. 2014;40(7):1840–1845. doi:10.1111/jog.12433
   PubMed Web of Science ®Google Scholar
• Bujold E, Roberge S, Lacasse Y, et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstetrics Gynecol. 2010;116(2):402–414. doi:10.1097/AOG.0b013e3181e9322a
   PubMed Web of Science ®Google Scholar
• Scharf RE. Platelet signaling in primary haemostasis and arterial thrombus formation: part 1. Hamostaseologie. 2018;38(4):203–210. doi:10.1055/s-0038-1675144
   PubMed Web of Science ®Google Scholar
• Missfelder‐Lobos H, Teran E, Lees C, Albaiges G, Nicolaides K. Platelet changes and subsequent development of pre‐eclampsia and fetal growth restriction in women with abnormal uterine artery Doppler screening. Ultrasound Obstetrics Gynecol. 2002;19(5):443–448. doi:10.1046/j.1469-0705.2002.00672.x
   PubMed Web of Science ®Google Scholar
• Gioia S, Piazze J, Anceschi M, et al. Mean platelet volume: association with adverse neonatal outcome. Platelets. 2007;18(4):284–288. doi:10.1080/09537100601078448
   PubMed Web of Science ®Google Scholar
• Karin N. The multiple faces of CXCL12 (SDF‐1α) in the regulation of immunity during health and disease. J Leukoc Biol. 2010;88(3):463–473. doi:10.1189/jlb.0909602
   Web of Science ®Google Scholar
• Jalili A, Shirvaikar N, Marquez-Curtis L, et al. Fifth complement cascade protein (C5) cleavage fragments disrupt the SDF-1/CXCR4 axis: further evidence that innate immunity orchestrates the mobilization of hematopoietic stem/progenitor cells. Exp Hematol. 2010;38(4):321–332. doi:10.1016/j.exphem.2010.02.002
   Web of Science ®Google Scholar
• Quinn KE, Reynolds LP, Grazul-Bilska AT, Borowicz PP, Ashley RL. Placental development during early pregnancy: effects of embryo origin on expression of chemokine ligand twelve (CXCL12). Placenta. 2016;43:77–80. doi:10.1016/j.placenta.2016.05.008
   Web of Science ®Google Scholar
• Wang L, Li X, Zhao Y, et al. Insights into the mechanism of CXCL12-mediated signaling in trophoblast functions and placental angiogenesis. Acta Biochim Biophys Sin (Shanghai). 2015;47(9):663–672. doi:10.1093/abbs/gmv064
   Web of Science ®Google Scholar
• Hanna J, Goldman-Wohl D, Hamani Y, et al. Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat Med. 2006;12(9):1065. doi:10.1038/nm1452
   PubMed Web of Science ®Google Scholar
• Nagasawa T, Hirota S, Tachibana K, et al. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature. 1996;382(6592):635. doi:10.1038/382635a0
   PubMed Web of Science ®Google Scholar
• Tseng -J-J, Chen Y-F, Hsieh Y-T, Chou -M-M. Elevated amniotic fluid stromal cell-derived factor-1α (SDF-1α) concentration in mid-gestation as a predictor of adverse birth outcomes. J Chin Med Assoc. 2009;72(12):638–642. doi:10.1016/S1726-4901(09)70446-0
   Web of Science ®Google Scholar
• Figueras F, Gratacos E. Update on the diagnosis and classification of fetal growth restriction and proposal of a stage-based management protocol. Fetal Diagn Ther. 2014;36(2):86–98. doi:10.1159/000357592
   PubMed Web of Science ®Google Scholar
• Albu AR, Anca AF, Horhoianu VV, Horhoianu IA. Predictive factors for intrauterine growth restriction. J Med Life. 2014;7(2):165–171.
   PubMedGoogle Scholar
• ACOG Practice bulletin no. 134. fetal growth restriction. Obstet Gynecol. 2013;121(5):1122–1133.
   Google Scholar
• Hendrix N, Berghella V, editors. Non-Placental Causes of Intrauterine Growth Restriction. Seminars in Perinatology. Elsevier; 2008.
   Google Scholar
• Tomaiuolo M, Brass LF, Stalker TJ. Regulation of platelet activation and coagulation and its role in vascular injury and arterial thrombosis. Intervent Cardiol Clin. 2017;6(1):1–12. doi:10.1016/j.iccl.2016.08.001
   PubMedGoogle Scholar
• Norris LA, Sheppard BL, Burke G, Bonnar J. Platelet activation in normotensive and hypertensive pregnancies complicated by intrauterine growth retardation. Br J Obstet Gynaecol. 1994;101(3):209–214. doi:10.1111/j.1471-0528.1994.tb13111.x
   Google Scholar
• Piazze J, Gioia S, Maranghi L, Anceschi M. Mean platelet and red blood cell volume measurements to estimate the severity of hypertension in pregnancy. J Perinat Med. 2006;34(3):246–247. doi:10.1515/JPM.2006.044
   PubMed Web of Science ®Google Scholar
• Thalor N, Singh K, Pujani M, Chauhan V, Agarwal C, Ahuja R. A correlation between platelet indices and preeclampsia. Hematol Transfusion Cell Ther. 2019;41(2):129–133. doi:10.1016/j.htct.2018.08.008
   Google Scholar
• Müllers SM, Burke N, Flood K, et al. Altered platelet function in intrauterine growth restriction: a cause or a consequence of uteroplacental disease? Am J Perinatol. 2016;33(08):791–799. doi:10.1055/s-0036-1572428
   Web of Science ®Google Scholar
• Ahmed Y, Sullivan MH, Pearce JM, Elder MG. Changes in platelet function in pregnancies complicated by fetal growth retardation. Eur J Obstetrics Gynecol Reprod Biol. 1991;42(3):171–175. doi:10.1016/0028-2243(91)90215-7
   Web of Science ®Google Scholar
• Groom KM, David AL. The role of aspirin, heparin, and other interventions in the prevention and treatment of fetal growth restriction. Am J Obstet Gynecol. 2018;218(2s):S829–S840. doi:10.1016/j.ajog.2017.11.565
   PubMed Web of Science ®Google Scholar
• Ayala DE, Ucieda R, Hermida RC. Chronotherapy with low-dose aspirin for prevention of complications in pregnancy. Chronobiol Int. 2013;30(1–2):260–279. doi:10.3109/07420528.2012.717455
   PubMed Web of Science ®Google Scholar
• McCowan LM, Figueras F, Anderson NH. Evidence-based national guidelines for the management of suspected fetal growth restriction: comparison, consensus, and controversy. Am J Obstet Gynecol. 2018;218(2s):S855–S868. doi:10.1016/j.ajog.2017.12.004
   PubMed Web of Science ®Google Scholar
• Levine RJ, Lam C, Qian C, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med. 2006;355(10):992–1005. doi:10.1056/NEJMoa055352
   PubMed Web of Science ®Google Scholar
• Ahmed A, Dunk C, Ahmad S, Khaliq A. Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (PlGF) and soluble Flt-1 by oxygen—a review. Placenta. 2000;21:S16–S24. doi:10.1053/plac.1999.0524
   PubMed Web of Science ®Google Scholar
• Mayhew T, Charnock-Jones D, Kaufmann P. Aspects of human fetoplacental vasculogenesis and angiogenesis. III. Changes in complicated pregnancies. Placenta. 2004;25(2–3):127–139.
   PubMed Web of Science ®Google Scholar
• Jaleel MA, Tsai AC, Sarkar S, Freedman PV, Rubin LP. Stromal cell-derived factor-1 (SDF-1) signalling regulates human placental trophoblast cell survival. Mol Hum Reprod. 2004;10(12):901–909. doi:10.1093/molehr/gah118
   Web of Science ®Google Scholar
• Hwang HS, Kwon HS, Sohn IS, Park YW, Kim YH. Increased CXCL12 expression in the placentae of women with pre-eclampsia. Eur J Obstetrics Gynecol Reprod Biol. 2012;160(2):137–141. doi:10.1016/j.ejogrb.2011.10.007
   Web of Science ®Google Scholar
• Red-Horse K, Drake PM, Gunn MD, Fisher SJ. Chemokine ligand and receptor expression in the pregnant uterus: reciprocal patterns in complementary cell subsets suggest functional roles. Am J Pathol. 2001;159(6):2199–2213. doi:10.1016/S0002-9440(10)63071-4
   Web of Science ®Google Scholar
• Schanz A, Winn VD, Fisher SJ, et al. Pre-eclampsia is associated with elevated CXCL12 levels in placental syncytiotrophoblasts and maternal blood. Eur J Obstetrics Gynecol Reprod Biol. 2011;157(1):32–37. doi:10.1016/j.ejogrb.2011.02.023
   Web of Science ®Google Scholar
• Rajakumar A, Michael HM, Rajakumar PA, et al. Extra-placental expression of vascular endothelial growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women. Placenta. 2005;26(7):563–573. doi:10.1016/j.placenta.2004.09.001
   PubMed Web of Science ®Google Scholar
• Massberg S, Konrad I, Schürzinger K, et al. Platelets secrete stromal cell–derived factor 1α and recruit bone marrow–derived progenitor cells to arterial thrombi in vivo. J Exp Med. 2006;203(5):1221–1233. doi:10.1084/jem.20051772
   PubMed Web of Science ®Google Scholar
• Askari AT, Unzek S, Popovic ZB, et al. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. The Lancet. 2003;362(9385):697–703. doi:10.1016/S0140-6736(03)14232-8
   PubMed Web of Science ®Google Scholar
• Dimova I, Karthik S, Makanya A, et al. SDF-1/CXCR4 signalling is involved in blood vessel growth and remodelling by intussusception. J Cell Mol Med. 2019;23(6):3916–3926. doi:10.1111/jcmm.14269
   Web of Science ®Google Scholar